46 /100
MEDIUM RISK
Score updated Jul 14, 2026

ENLV — Enlivex Ltd. Dilution Risk Tracker

Track ENLV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENLV — Get alerts when the score changes →

As of July 14, 2026, Enlivex Ltd. (ENLV) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. Enlivex Ltd. has a market capitalization of $195.32M, 237.38M shares outstanding, 36 institutional holders tracked. Key dilution vectors include approximately 32 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
52
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.86 below $1 exchange minimum
🔔 Track ENLV — Get forecast alerts →

💹 Market Data

Market Cap$195.32M
Shares Outstanding237.38M
Float57.72M
Cash$27.34M
Debt$32.60M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 195.6% shares (2026Q1 vs prior)
36 institutional holders · 4.04M shares
#1 Diametric Capital, LP 1.48M shares
#2 ARK Investment Management LLC 628.3K shares
#3 MORGAN STANLEY 472.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.51M
Days to Cover4.0
% of Float2.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2013
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ENLV Shareholders

Enlivex Ltd. (ENLV) has a DilutionScore of 46/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for ENLV shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ENLV in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ENLV alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ENLV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENLV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ENLV
📊 ENLV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ENLV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.